title: Chemotherapy induced peripheral neuropathic pain.
abstract: Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most serious complications associated with anticancer drugs. CIPN leads to a lower quality of life and dysfunction of the sensory, motor, and autonomic systems, and often causes patients to discontinue chemotherapy. It is usually misdiagnosed and undertreated due to a lack of consensus and unclear pathophysiology, for which many mechanisms have been suggested, including mitochondrial dysfunction, various pain mediators, abnormal spontaneous discharge in A and C fibers, and others. To date, no agents have been shown to effectively prevent CIPN, leading to debate as to the standard protocol. Duloxetine has demonstrated a moderate therapeutic effect against CIPN. Although tricyclic antidepressants (such as nortriptyline or desipramine), gabapentin, and a topical gel containing baclofen (10 mg), amitriptyline HCL (40 mg), and ketamine (20 mg) showed inconclusive results in CIPN trials, these agents are currently considered the best options for CIPN treatment. Therefore, further studies on the pathophysiology and treatment of CIPN are needed.
authors.affiliation: Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
authors.forename: Hue Jung
authors.initials: HJ
authors.lastname: Park
keywords: Cancer; Chemotherapy; Pain; Peripheral neuropathy
references.citation: Oncologist. 2010;15 Suppl 2:9-12
references.pmid: 20489191
references.citation: J Pain Symptom Manage. 2014 Jan;47(1):166-73
references.pmid: 23742737
references.citation: Neurotoxicology. 2009 Mar;30(2):312-9
references.pmid: 19428505
references.citation: Clin Nutr. 2013 Dec;32(6):888-93
references.pmid: 23647723
references.citation: Neurosci Lett. 2002 Apr 5;322(2):103-6
references.pmid: 11958854
references.citation: Neurosci Lett. 2006 Apr 24;397(3):219-23
references.pmid: 16406309
references.citation: J Pharmacol Exp Ther. 2006 Dec;319(3):1376-85
references.pmid: 16982702
references.citation: Pain. 2009 Dec 15;147(1-3):202-9
references.pmid: 19833436
references.citation: J Clin Oncol. 2008 Sep 20;26(27):4519-20
references.pmid: 18802169
references.citation: Prog Neurobiol. 2005 Dec;77(5):299-352
references.pmid: 16356622
references.citation: Cancer Res. 2005 May 1;65(9):3828-36
references.pmid: 15867381
references.citation: Curr Opin Support Palliat Care. 2011 Mar;5(1):1-7
references.pmid: 21192267
references.citation: Neurobiol Dis. 2011 Mar;41(3):661-8
references.pmid: 21145397
references.citation: J Neurosci. 1998 Aug 15;18(16):6480-91
references.pmid: 9698336
references.citation: Food Chem Toxicol. 2011 Oct;49(10):2557-63
references.pmid: 21756962
references.citation: Exp Neurol. 2008 Mar;210(1):229-37
references.pmid: 18078936
references.citation: Neurosci Lett. 2008 Nov 14;445(2):140-3
references.pmid: 18790011
references.citation: AANA J. 2008 Oct;76(5):335-9
references.pmid: 18947160
references.citation: J Neurol. 2002 Jan;249(1):9-17
references.pmid: 11954874
references.citation: Pain. 2008 Apr;135(3):262-270
references.pmid: 17659836
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14374-9
references.pmid: 12391322
references.citation: Minerva Anestesiol. 2006 Mar;72(3):151-69
references.pmid: 16493391
references.citation: Anesth Analg. 2013 Jan;116(1):224-31
references.pmid: 23223118
references.citation: Pain. 2004 May;109(1-2):150-61
references.pmid: 15082137
references.citation: Anticancer Res. 2010 Jul;30(7):2927-33
references.pmid: 20683034
references.citation: Anesth Analg. 2006 May;102(5):1485-90
references.pmid: 16632831
references.citation: Pain. 2006 Jun;122(3):245-257
references.pmid: 16530964
references.citation: J Pain Symptom Manage. 2010 Jun;39(6):e2-4
references.pmid: 20538177
references.citation: Exp Neurol. 2006 Oct;201(2):507-14
references.pmid: 16797537
references.citation: J Pain. 2007 Apr;8(4):296-306
references.pmid: 17175202
references.citation: Eur J Neurosci. 2004 Dec;20(11):2896-902
references.pmid: 15579143
references.citation: Eur J Pharmacol. 2008 Sep 11;592(1-3):87-92
references.pmid: 18652822
references.citation: J Clin Oncol. 2014 Jun 20;32(18):1941-67
references.pmid: 24733808
references.citation: Neurology. 2005 Jan 11;64(1):26-31
references.pmid: 15642899
references.citation: JAMA. 2013 Aug 7;310(5):538
references.pmid: 23925632
references.citation: Crit Rev Oncol Hematol. 2012 Apr;82(1):51-77
references.pmid: 21908200
references.citation: JAMA. 2013 Apr 3;309(13):1359-67
references.pmid: 23549581
references.citation: Eur J Cancer. 2008 Jul;44(11):1507-15
references.pmid: 18571399